Tumor Microenvironment and Intracellular Signal-Activated Nanocomposites for Anticancer Drug Delivery

Author(s):  
Yilan Huang ◽  
Yiheng Huang ◽  
Yuefei Zhu ◽  
Xiaowen Zhu ◽  
Zhiqing Pang
2020 ◽  
Vol 17 (5) ◽  
pp. 1516-1526 ◽  
Author(s):  
Nan Jia ◽  
Wenpan Li ◽  
Dan Liu ◽  
Shiyang Wu ◽  
Baohui Song ◽  
...  

2020 ◽  
Vol 8 (26) ◽  
pp. 5745-5755
Author(s):  
Rimesh Augustine ◽  
Dae-Kyoung Kim ◽  
Nagendra Kalva ◽  
Kuen Hee Eom ◽  
Jae Ho Kim ◽  
...  

A poly(lysine)-synthetic polymer hybrid nanomicelles were fabricated as promising platform for efficient tumor targeting and glutathione/pH/temperature-responsive anticancer drug delivery.


2015 ◽  
Vol 3 (20) ◽  
pp. 4221-4230 ◽  
Author(s):  
Yuan Zhan ◽  
Mara Gonçalves ◽  
Panpan Yi ◽  
Débora Capelo ◽  
Yuhong Zhang ◽  
...  

Doxorubicin is effectively loaded into disulfide-crosslinked poly(N-isopropylacrylamide-co-acrylic acid) nanogels, which can be triggerably released in a heating or reducing acidic tumor microenvironment.


2015 ◽  
Vol 22 (21) ◽  
pp. 2525-2538 ◽  
Author(s):  
Enrica Calce ◽  
Luca Monfregola ◽  
Michele Saviano ◽  
Stefania De Luca

2020 ◽  
Vol 26 (15) ◽  
pp. 1637-1649 ◽  
Author(s):  
Imran Ali ◽  
Sofi D. Mukhtar ◽  
Heyam S. Ali ◽  
Marcus T. Scotti ◽  
Luciana Scotti

Background: Nanotechnology has contributed a great deal to the field of medical science. Smart drugdelivery vectors, combined with stimuli-based characteristics, are becoming increasingly important. The use of external and internal stimulating factors can have enormous benefits and increase the targeting efficiency of nanotechnology platforms. The pH values of tumor vascular tissues are acidic in nature, allowing the improved targeting of anticancer drug payloads using drug-delivery vectors. Nanopolymers are smart drug-delivery vectors that have recently been developed and recommended for use by scientists because of their potential targeting capabilities, non-toxicity and biocompatibility, and make them ideal nanocarriers for personalized drug delivery. Method: The present review article provides an overview of current advances in the use of nanoparticles (NPs) as anticancer drug-delivery vectors. Results: This article reviews the molecular basis for the use of NPs in medicine, including personalized medicine, personalized therapy, emerging vistas in anticancer therapy, nanopolymer targeting, passive and active targeting transports, pH-responsive drug carriers, biological barriers, computer-aided drug design, future challenges and perspectives, biodegradability and safety. Conclusions: This article will benefit academia, researchers, clinicians, and government authorities by providing a basis for further research advancements.


Sign in / Sign up

Export Citation Format

Share Document